Related Experiment Video
Updated: May 6, 2026
05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
13.0K
Immunological aspects of atherosclerosis
S Garrido-Urbani1, M Meguenani, F Montecucco
1Department of Pathology and Immunology, CMU, University of Geneva, Geneva, Switzerland, sarah.garrido-urbani@unige.ch.
Seminars in Immunopathology
|November 12, 2013
Summary
Atherosclerosis is an inflammatory disease where immune cells and lipids thicken artery walls, leading to heart and brain conditions. This review details the immune system's critical role in its development and mechanisms.
Area of Science:
- Immunology
- Cardiovascular Science
- Metabolic Disease Research
Background:
- Atherosclerosis is a chronic inflammatory and metabolic disease.
- It involves multiple immune system cells, lipids, and soluble molecules.
- It is the leading cause of coronary artery and cerebrovascular diseases.
Purpose of the Study:
- To review the immune system's role in atherosclerosis.
- To discuss the mechanisms underlying immune involvement in disease development.
Main Methods:
- Literature review of immunological and cardiovascular studies.
- Analysis of cellular and molecular mechanisms in atherosclerosis.
Main Results:
- Immune cell subsets, chemokines, cytokines, and lipids are pivotal.
- These factors contribute to arterial wall thickening.
- The immune system is central to atherosclerotic disease progression.
Conclusions:
- The immune system plays a critical role in atherosclerosis.
- Understanding these mechanisms is key for therapeutic strategies.
- Further research into immune pathways is warranted.
Related Concept Videos
01:30Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
01:38Inflammation
46.8K
Overview
46.8K
01:26Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747